Dr Narin Osman is a Senior Research Fellow and the Deputy Group Leader of the Diabetes Complications Group.
Cell signaling pathways that regulate extracellular matrix form and function with a focus on vascular disease and diabetes; cell biology of proteoglycans and glycosaminoglycans in health and disease; identification of drug targets for the prevention of cardiovascular diseases and diabetes.
After a Post-doctoral Fellowship at the Imperial Cancer Research Fund in the UK, Narin returned to Melbourne to take up a Senior Research Fellowship at the Austin Research Institute followed by a position at the Cell Biology of Diabetes Laboratory within the Baker Heart Research Institute.
Narin has continued to explore the role of proteoglycans in disease and her current research interests include cell signaling pathways that regulate extracellular matrix form and function with a focus on vascular disease and diabetes; cell biology of proteoglycans and glycosaminoglycans; identification of pharmaceutical targets for the prevention of diseases involving modified proteoglycans; Proteoglycans and age-related macular degeneration (AMD); and Tinibs as potential drugs for diabetes complications.
Narin was awarded a Vice-Chancellor's Senior Research Fellowship in 2014 and is aligned with the School of Health and Biomedical Sciences.